Noble Pharma

Noble Pharma Co., Ltd. is a Japanese pharmaceutical company dedicated to the development and commercialization of orphan drugs and treatments for unmet medical needs. The company focuses on identifying promising drug candidates from academia and other pharmaceutical firms that have been stalled in development due to small patient populations. Noble Pharma is best known for its work in tuberous sclerosis complex (TSC) and pediatric conditions, successfully bringing products like Rapalimus (sirolimus) to market. Their business model emphasizes efficient clinical development and regulatory navigation for rare diseases. The company maintains strong ties with Japanese academic institutions to bridge the gap between basic research and clinical application.